Investing Profile

Jason Rhodes

Photo of Jason Rhodes, Partner at Atlas Venture

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Atlas Venture Partner
$500K - $5.0M
CompanyStageDateRound SizeTotal Raised
Accent Therapeutics
Series AMay 2018$40M
Co-investors: Larry Lasky (The Column Group)
Generation Bio
Series AJan 2018$25M
Gemini Therapeutics
Series AOct 2017$43M
Co-investors: Carl Gordon (OrbiMed), Stephen Squinto (OrbiMed), Jean George (Lightstone VC)
Disarm Therapeutics
Series ASep 2017$30M
Replimune Group
Series ASep 2015$30M
Co-investors: Brett Zbar (Foresite Capital)
Raze Therapeutics
Series AOct 2014$24M
Co-investors: Peter Barrett (Atlas Venture)